Value of Computed Tomography-Defined Sarcopenia: A Prognostic Predictor of Non-Relapse Mortality Following Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Acute Myeloid Leukemia and Myelodysplastic Syndrome
Taiki Ando(Kanagawa Prefectural Hospital Organization), Hideaki Nakajima(National Institute of Advanced Industrial Science and Technology), Kazuho Miyashita(Fujisawa City Hospital), Shin Fujisawa(Yokohama City University Medical Center), Ayako Matsumura(Yokohama City University), Kenji Matsumoto(RIKEN Center for Brain Science), Hiroyuki Takahashi(Yokohama City University), Maki Hagihara(Yokohama City University Hospital), Akiko Negoro(Yokohama City University), Haruka Teshigawara(Yokohama City University), Takayuki Sakuma(Yokohama City University), Hiroshi Teranaka(Yokohama City University Medical Center), Yoshimi Ishii(Yokohama City University Medical Center), Yuki Nakajima(Fujisawa City Hospital), Jun Aoki(Kanagawa Prefectural Hospital Organization), Takuya Miyazaki(Kanagawa Prefectural Hospital Organization), Eriko Ogusa(Yokohama City University Medical Center), Etsuko Yamazaki(Yokohama City University), Taisei Suzuki(Hiratsuka City Hospital)
Cited by 3
Related Papers
Medial prefrontal cell activity signaling prediction errors of action values
|Nature Neuroscience|2007|452
AML1 mutations induced MDS and MDS/AML in a mouse BMT model
|Blood|2008|149
Monitoring of Hepatitis B Virus (HBV) DNA and Risk of HBV Reactivation in B-Cell Lymphoma: A Prospective Observational Study
|Clinical Infectious Diseases|2015|149